Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

1. Sanmamed, M.F.
2. Rodriguez, I.
3. Schalper, K.A.
4. Oñate, C.
5. Azpilikueta, A.
6. Rodriguez-Ruiz, M.E.
7. Morales-Kastresana, A.
8. Labiano, S.
9. Pérez-Gracia, J.L.
10. Martín-Algarra, S.
11. Alfaro, C.
12. Mazzolini, G.
13. Sarno, F.
14. Hidalgo, M.
15. Korman, A.J.
16. Jure-Kunkel, M.
17. Melero, I.